Testing effectiveness (Phase 2)Study completedNCT05774184What this trial is testingCDX-0159 in Patients With Eosinophilic EsophagitisWho this might be right forEosinophilic Esophagitis Celldex Therapeutics 86
Very early researchLooking for participantsNCT06385652What this trial is testingPET Imaging Study of 68Ga-NB381 in Multiple MyelomaWho this might be right forMultiple Myeloma Peking University First Hospital 30
Early research (Phase 1)Looking for participantsNCT05945849What this trial is testingCD33KO-HSPC Infusion Followed by CART-33 Infusion(s) for Refractory/Relapsed AMLWho this might be right forLeukemia, Myeloid, Acute University of Pennsylvania 16
Testing effectiveness (Phase 2)Study completedNCT04992949What this trial is testingEvaluation of CPX-351 Monotherapy in Acute Myeloid Leukemia Secondary to Myeloproliferative NeoplasmWho this might be right forAcute Myeloid LeukemiaMyeloproliferative Syndrome French Innovative Leukemia Organisation 42
Testing effectiveness (Phase 2)WithdrawnNCT06085638What this trial is testingPhase I/II Study of SY-1425 (Tamibarotene) in Combination With Azacitidine and Venetoclax for Patients With Chronic Myelomonocytic LeukemiaWho this might be right forChronic Myelomonocytic Leukemia M.D. Anderson Cancer Center
Very early researchUnknownNCT04186052What this trial is testingClinical Trial of BCMA CAR T Cell Infusion in Patients With BCMA-positive r/r Multiple MyelomaWho this might be right forMultiple Myeloma PersonGen BioTherapeutics (Suzhou) Co., Ltd. 10
Not applicableNot Yet RecruitingNCT05440747What this trial is testingTreatment Free Remission (TFR) in CML Patients （CML-CP）StudyWho this might be right forChronic Myeloid LeukemiaTreatment-free Remission Guangdong Provincial People's Hospital 203
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07516847What this trial is testingDapagliflozin for Anemia in Lower-Risk Myelodysplastic SyndromesWho this might be right forMyelodysplastic Syndromes (MDS)Anemia Seug yun Yoon, MD 37
Large-scale testing (Phase 3)Ended earlyNCT00109538What this trial is testingStudy of Lonafarnib Versus Placebo in Subjects With Either Myelodysplastic Syndrome (MDS) or Chronic Myelomonocytic Leukemia (CMML) (Study P02978AM3)(TERMINATED)Who this might be right forMyelodysplastic SyndromesLeukemia, Myelomonocytic, ChronicMyelodysplasia+1 more Merck Sharp & Dohme LLC 47
Not applicableStudy completedNCT07249138What this trial is testingImpact of Congenital Heart Disease on the Prognosis of Childhood Hematological Neoplasms: A Multicenter Cohort StudyWho this might be right forCongenital Heart Disease (CHD)Hematologic Malignancy Children's Hospital of Fudan University 800
Testing effectiveness (Phase 2)Active Not RecruitingNCT05656248What this trial is testingStudy of CPX-351 (VYXEOS) in Individuals < 22 Years With Secondary Myeloid NeoplasmsWho this might be right forMyeloid Neoplasm St. Jude Children's Research Hospital 25
Testing effectiveness (Phase 2)Active Not RecruitingNCT06098326What this trial is testingCyFluATG in Lower Risk MDSWho this might be right forMyelodysplastic Syndromes Asan Medical Center 30
Not applicableUnknownNCT06476535What this trial is testingObservatory of Patients With MyeloProliferative Neoplasm Treated With Anti-inflammatory ImmunotherapyWho this might be right forMyeloproliferative NeoplasmInflammatory Disease University Hospital, Brest 100
Early research (Phase 1)UnknownNCT03840317What this trial is testingSenl_1904A and Senl_1904B Chimeric Antigen Receptor （CAR） T-Cell in the Treatment of r/ r Acute B Lymphocytic LeukemiaWho this might be right forAcute Lymphocytic Leukemia Hebei Senlang Biotechnology Inc., Ltd. 20
Testing effectiveness (Phase 2)Study completedNCT01865617What this trial is testingLaboratory Treated T Cells in Treating Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia, Non-Hodgkin Lymphoma, or Acute Lymphoblastic LeukemiaWho this might be right forCD19-Positive Neoplastic Cells PresentRecurrent Adult Acute Lymphoblastic LeukemiaRecurrent Chronic Lymphocytic Leukemia+10 more Fred Hutchinson Cancer Center 204
Large-scale testing (Phase 3)Not Yet RecruitingNCT07735117What this trial is testingMitoxantrone Hydrochloride Liposome, Cytarabine, G-CSF Plus Venetoclax vs. Azacitidine Plus Venetoclax for MDS-IB2 and Secondary/Elderly AMLWho this might be right forAcute Myeloid Leukemia (AML)Myelodysplastic Syndromes (MDS) Ruijin Hospital 168
Early research (Phase 1)Looking for participantsNCT06854640What this trial is testingLearn About How Safe BAY 3389934 is, Its Suitable Dose, and How it Affects the Participants With Sepsis Induced CoagulopathyWho this might be right forSepsisCoagulopathy Bayer 36
Early research (Phase 1)Study completedNCT00047489What this trial is testingStudy of ABT-751 in Patients With Refractory Hematologic MalignanciesWho this might be right forHematological Malignancies M.D. Anderson Cancer Center 32
Not applicableStudy completedNCT00969891What this trial is testingStudy of Dosage Individualisation for the Treatment of Acute Myeloid LeukemiaWho this might be right forAcute Myeloid Leukemia Mikkel Krogh-Madsen 23
Not applicableEnded earlyNCT00513318What this trial is testingPilot Study of Reduced-Intensity Umbilical Cord Blood Transplantation in Adult Patients Wtih Advanced Hematopoietic MalignanciesWho this might be right forAcute Myeloid LeukemiaMyelodysplasiaAcute Lymphoblastic Leukemia+4 more University of California, San Francisco 15